Ajanta Pharma promoter adjusts share pledges for refinancing

Ravi Agrawal, a promoter of Ajanta Pharma Limited and trustee of Ravi Agrawal Trust, reported the creation and simultaneous release of pledges on 40,000 equity shares of the company on September 24, 2025. The creation of the pledge was for refinancing, while the release of the pledge was due to an excess pledge.

Specifically, 40,000 shares were pledged as part of business financing to Infina Finance Private Limited, with Barclays Securities (India) Private Limited as the DP. Concurrently, 40,000 shares were released from a pledge, also for business financing, from Deutsche Investments India Private Limited, again with Barclays Securities (India) Private Limited as the DP.

Following these transactions, Ravi P. Agrawal, trustee Ravi Agrawal Trust, maintained a holding of 16,242,904 shares (13.00% of total share capital), with 6,007,642 shares (4.81% of total share capital) remaining encumbered. The reporting date for these disclosures was September 25, 2025.